Device Trial Radar · NCT07059793
MITRIS China Post Market Clinical Follow-up (PMCF) Study
Last checked: Nov 20, 2026Latest source record: Dec 30, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
250
Planned (sponsor's estimate)
Start
Jul 8, 2025
Primary completion
Dec 2028
Study completion Dec 2038
Sponsor
- Lead sponsor
- Edwards LifesciencesPublic (EW)
- Sponsor type
- Industry
- Collaborators
- Edwards (Shanghai) Medical Products Co. Ltd.; Kun Tuo Medical Research and Development (Beijing) Co. Ltd.; Chinese Academy of Medical Sciences, Fuwai Hospital
- First posted
- Jul 11, 2025
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Collect clinical outcomes on acute and long-term safety and performance of the MITRIS RESILIA Mitral Valve, Model 11400M, in subjects requiring replacement of their native or prosthetic mitral valve with or without concomitant procedures.
Conditions
- Mitral Valve Replacement
Interventions
MITRIS RESILIA Mitral ValveDevice
Surgical replacement of native or prosthetic mitral valve.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Safety outcome - Kaplan Meier (KM) rate of valve related death or reinterventionTime frame: 1 year
- Primary Performance outcome - Hemodynamics by echocardiography - Subject's Average Mean Gradient MeasurementsTime frame: 1 year
- Primary Performance outcome - Hemodynamics by echocardiography - Subject's Average Peak Gradients MeasurementsTime frame: 1 year
2 more outcomes with a free account
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Beijing Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality, China · Recruiting
Fuwai Hospital, CAMS & PUMC
Beijing, Beijing Municipality, China · Recruiting
Xiamen Cardiovascular Hospital Xiamen University
Xiamen, Fujian, China · Recruiting
10 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.